Trial intelligence / Profile preview

Phase II ADV-TK plus ganciclovir for late-stage primary hepatocellular carcinoma

ChiCTR-ONRC-11001233Phase 2Completed

Sponsor

Shenzhen Tiandakang Gene Engineering

Start

Nov 2007

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1